Full Breakdown
DOJ Warns Letitia James Over Transgender Treatment Dispute
3/20/2026, 3:03:47 AM
Legal Conflict Over Transgender Treatments for Minors
The Department of Justice (DOJ) has issued a warning to New York Attorney General Letitia James regarding her actions against NYU Langone Health, which recently ceased certain transgender treatments for minors. Deputy Attorney General Todd Blanche articulated the DOJ's position in a letter, asserting that federal law does not mandate the hospital to provide these treatments and that James' claims of discrimination are unfounded. The DOJ indicated it would support NYU Langone in any potential litigation initiated by James, emphasizing the hospital's discretion in medical decisions related to gender treatments.
Background of NYU Langone's Decision
NYU Langone Health decided to discontinue its Transgender Youth Health Program following the departure of its medical director and concerns over federal funding threats. The hospital's spokesperson, Steve Ritea, clarified that the cessation of the program does not affect its pediatric mental health services. The program had previously offered hormone therapies, including puberty blockers, to minors.
Attorney General's Position
In response to NYU Langone's decision, Letitia James threatened legal action, demanding the hospital reinstate its transgender treatment program within ten days. James contended that the hospital's policy change was self-imposed and that there had been no alteration in federal law necessitating the discontinuation of medically necessary transgender healthcare.
DOJ's Legal Justification
Blanche's letter referenced the Supreme Court's ruling in United States v. Skrmetti, which upheld Tennessee's ban on certain transgender medical care for minors. He argued that NYU Langone's policy is based on medical diagnosis rather than gender identity, allowing transgender minors to access treatments for conditions other than gender dysphoria. This distinction, according to Blanche, negates the claim of discrimination under state law.
Criticism & Opposition
Critics of the DOJ's stance, including James, argue that the cessation of transgender treatments for minors constitutes a violation of anti-discrimination laws. James maintains that the hospital's actions undermine the rights of transgender youth to receive necessary medical care.
Official Statements & Responses
The DOJ's letter emphasized that NYU Langone's decision does not equate to discrimination based on sex, gender identity, or disability. Blanche stated, "NYU Langone's exercise of its sound discretion to not provide such services and procedures does not constitute discrimination on any of these grounds."
What's Next
As the situation develops, it remains to be seen whether James will proceed with legal action against NYU Langone Health. The outcome could have significant implications for the provision of transgender healthcare for minors in New York and potentially influence similar policies across the country.
